Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 28 3 2020
Statut: ppublish

Résumé

We evaluate the utility of the National Surveys of Attitudes and Sexual Lifestyles (Natsal) undertaken in 2000 and 2010, before and after the introduction of the National Chlamydia Screening Programme, as an evidence source for estimating the change in prevalence of Chlamydia trachomatis (CT) in England, Scotland and Wales. Both the 2000 and 2010 surveys tested urine samples for CT by Nucleic Acid Amplification Tests (NAATs). We examined the sources of uncertainty in estimates of CT prevalence change, including sample size and adjustments for test sensitivity and specificity, survey non-response and informative non-response. In 2000, the unadjusted CT prevalence was 4.22% in women aged 18-24 years; in 2010, CT prevalence was 3.92%, a non-significant absolute difference of 0.30 percentage points (95% credible interval -2.8 to 2.0). In addition to uncertainty due to small sample size, estimates were sensitive to specificity, survey non-response or informative non-response, such that plausible changes in any one of these would be enough to either reverse or double any likely change in prevalence. Alternative ways of monitoring changes in CT incidence and prevalence over time are discussed.

Identifiants

pubmed: 30869031
pii: S0950268819000347
doi: 10.1017/S0950268819000347
pmc: PMC6518515
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e107

Subventions

Organisme : Medical Research Council
ID : G0701757
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801947
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

Stat Med. 1999 Nov 30;18(22):2987-3003
pubmed: 10544302
J Clin Microbiol. 2002 Oct;40(10):3757-63
pubmed: 12354877
J Clin Microbiol. 2004 Jul;42(7):3041-5
pubmed: 15243057
BMJ. 2005 Apr 23;330(7497):940
pubmed: 15809231
Sex Transm Dis. 2005 Jun;32(6):387-94
pubmed: 15912087
J Clin Microbiol. 2006 Jul;44(7):2512-7
pubmed: 16825373
Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165
pubmed: 17311735
Int J Epidemiol. 2009 Apr;38(2):435-48
pubmed: 19060033
J Fam Plann Reprod Health Care. 2009 Jan;35(1):21-6
pubmed: 19126312
Int J Epidemiol. 2012 Dec;41(6):1585-93
pubmed: 22253315
BMJ. 2012 Jul 05;345:e4316
pubmed: 22767614
Stat Med. 2013 Apr 30;32(9):1547-60
pubmed: 22949217
Sex Transm Infect. 2013 Feb;89(1):70-5
pubmed: 23024225
PLoS One. 2013 Aug 21;8(8):e72001
pubmed: 23991024
Sex Transm Infect. 2014 Mar;90(2):84-9
pubmed: 24277881
Lancet. 2013 Nov 30;382(9907):1781-94
pubmed: 24286784
Lancet. 2013 Nov 30;382(9907):1795-806
pubmed: 24286785
Sex Transm Infect. 2016 May;92(3):218-27
pubmed: 26290483
Stat Med. 2016 Apr 30;35(9):1454-70
pubmed: 26555849
Health Technol Assess. 2016 Mar;20(22):1-250
pubmed: 27007215
Sex Transm Infect. 2017 Jun;93(4):276-283
pubmed: 27979910
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183393
Epidemiology. 2017 Jul;28(4):492-502
pubmed: 28306613
Lancet Public Health. 2018 Jun;3(6):e271-e278
pubmed: 29776798
Lancet Public Health. 2018 Sep;3(9):e416
pubmed: 30193695
J Clin Microbiol. 1994 Oct;32(10):2540-3
pubmed: 7814494
Lancet. 1995 Jan 28;345(8944):213-6
pubmed: 7823713
J Infect Dis. 1994 Nov;170(5):1308-11
pubmed: 7963734
Lancet. 1996 Aug 31;348(9027):592-3
pubmed: 8774575

Auteurs

D Z Kounali (DZ)

Population Health Sciences, Bristol Medical School,Oakfield House, Oakfield Grove, Bristol BS8 5BN,UK.

N J Welton (NJ)

Population Health Sciences, Bristol Medical School,Oakfield House, Oakfield Grove, Bristol BS8 5BN,UK.

K Soldan (K)

National Institute for Health Research Health Protection Research Unit in Evaluation of Interventions, University of Bristol,Bristol,UK.

S C Woodhall (SC)

Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division,Public Health England, London, 61 Colindale Avenue, London NW9 5EQ,UK.

J Kevin Dunbar (JK)

Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division,Public Health England, London, 61 Colindale Avenue, London NW9 5EQ,UK.

S J Migchelsen (SJ)

Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division,Public Health England, London, 61 Colindale Avenue, London NW9 5EQ,UK.

C H Mercer (CH)

Institute for Global Health, University College London, Mortimer Market Centre,London, WC1E 6JB,UK.

P Horner (P)

Population Health Sciences, Bristol Medical School,Oakfield House, Oakfield Grove, Bristol BS8 5BN,UK.

A E Ades (AE)

Population Health Sciences, Bristol Medical School,Oakfield House, Oakfield Grove, Bristol BS8 5BN,UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH